The good news is that treatment options for lung cancer patients are rapidly improving. In the last two years, more treatments have been approved by the United States Food and Drug Administration (FDA) for the treatment of lung cancer than had been approved in the prior ten years. New and life saving treatments, along with clinical trials, are happening rapidly and LCFA is committed to keeping you up to date on the latest, most hopeful and helpful, information.
From UC San Diego Health State’s long-term, aggressive tobacco control programs cited as primary reason Early adoption of tobacco control efforts in California led to fewer people ever smoking, reduced the amount used by those who do smok…
From Specialty Pharmacy Times Clinical Trial results: First-line immunotherapy combo fails: New study shows that first-line immunotherapy that uses durvalumab (Imfinzi, AstraZeneca) or the combination of durvalumab and tremelimumab failed t…
from Business Wire FDA Approves Atezolizumab in Combination Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approvedatezolizumab (Tecentriq®), in combination with Avastin® (bevac…
from The Hill Advances in Lung Cancer Treatment Advances in treatment have completely transformed the way that Americans are living with lung cancer, something that was unthinkable even ten years ago. Since 2015, the U.S. Food and Drug Ad…
from The Boston Globe I was only given months to live four years ago . . . I am still thriving John White, a retired North Attleborough bioengineer, was diagnosed in early 2015 with aggressive prostate cancer. It had spread to his bladder a…
From Market Watch: Personalized Medicine Entrectinib Shrank Tumors in People with NTRK Fusion-Positive Solid Tumors Entrectinib showed response irrespective of tumor type or spread to the central nervous system. Data will be submitted to …
From Helio: Women with newly diagnosed stage I to stage III non-small cell lung cancer (NSCLC) appeared to have longer overall survival than their male counterparts, according to results of a trial presented at International Association …
From Medscape: For the first time in decades, overall survival has been shown to improve in patients with extensive-stage small cell lung cancer (ES-SCLC) when concurrent immunotherapy is added to standard chemotherapy in the first-line set…
From US News Blood, saliva and even breath may one day be able to diagnose lung cancer. Lung Cancer is the no. 1 cancer killer in the U.S. "In fact, it kills more people than the next top three cancers combined," which are colorectal, brea…
From MedScape Air Pollution increases lung cancer risk in nonsmokers Among persons who have never smoked, women are far more susceptible than men to develop lung cancer when exposed to air pollution, new research shows. The finding…